FIBROGEN, INC.

FGEN
Delayed Quote. Delayed  - 01/15 04:00:00 pm
43.23USD +0.39%

Turn to zoom
Prev.43.0600
Open42.5700
High44.3600
Low41.3800
Volume1 752 357
Latest news
01/08
12/22
12/22
12/21
Chart FIBROGEN, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance44,249,048,8
Spread/Res.-2,3%-12%-11%
Spread/Supp.17%17%24%
Support37,137,135,0
Financials
Sales 2020 217 M - -
Net income 2020 -158 M - -
Net Debt 2020 - - -
P/E ratio 2020 -25,6x
Yield 2020 -
Capitalization 3 934 M 3 934 M -
Capi. / Sales 2020 18,1x
Capi. / Sales 2021 8,25x
Nbr of Employees 531
Free-Float 91,9%
Company
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-03-03 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 61,88 $
Last Close Price 43,23 $
Spread / Highest target 111%
Spread / Average Target 43,1%
Spread / Lowest Target 1,78%